Prodrug compounds with an oligopeptide having an isoleucine residue

Details for Australian Patent Application No. 2001266853 (hide)

Owner Medarex, Inc.

Inventors Gangwar, Sanjeev; Pickford, Lesley B.; Yarranton, Geoffrey T.; Nieder, Matthew H.; Lobl, Thomas J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001266853

PCT Pub. Number WO01/95943

Priority 60211686 14.06.00 US

Filing date 11 June 2001

Wipo publication date 24 December 2001

Acceptance publication date 17 February 2005

International Classifications

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 035/00 Antineoplastic agents

Event Publications

27 November 2003 Assignment before Grant

  Corixa Corporation The application has been assigned to Medarex, Inc.

17 February 2005 Application Accepted

  Published as AU-B-2001266853

16 June 2005 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001266854

2001266852